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At invasion, transformed mammary epithelial cells expand into the stroma
through a disrupted myoepithelial (ME) cell layer and basement membrane
(BM). The intact ME cell layer has thus been suggested to act as a barrier against
invasion. Here, we investigate the mechanisms behind the disruption of ME cell
layer. We show that the expression of basal/ME proteins CK5, CK14, and
a-SMA altered along increasing grade of malignancy, and their loss affected
the maintenance of organotypic 3D mammary architecture. Furthermore, our
data suggests that loss of CK5 prior to invasive stage causes decreased levels
of Zinc finger protein SNAI2 (SLUG), a key regulator of the mammary epithelial
cell lineage determination. Consequently, a differentiation bias toward luminal
epithelial cell type was detected with loss of mature, a-SMA-expressing ME cells
and reduced deposition of basementmembrane protein laminin-5. Therefore, our
data discloses the central role of CK5 in mammary epithelial differentiation and
maintenance of normal ME layer.
INTRODUCTION
Mammary gland parenchyme forms a ducto-lobular tree with a bilayered epithelium. The inner layer of
luminal epithelial (LE) cells is surrounded by a basal/myoepithelial layer, which comprises contractile my-
oepithelial (ME) cells, mammary stem cells, and epithelial progenitor cells, delimited by the basement
membrane (BM) from the connective tissue stroma. The basal cell layer is able to regenerate the whole
mammary gland epithelial tree (Böcker et al., 2002; Boecker and Buerger, 2003; Van Keymeulen et al.,
2011). Development of LE andME cells occurs in a complex hierarchical manner from the basal progenitors
that can differentiate into both epithelial cell types depending on numerous signaling pathways and hor-
monal stimuli (Arendt and Kuperwasser, 2015; Böcker et al., 2002; Boecker and Buerger, 2003; Boecker
et al., 2018; Van Keymeulen et al., 2011). This epithelial differentiation process can be followed as changes
in cell-type specific protein expression patterns, including expression of distinct cytokeratin (CK) family
members (Böcker et al., 2002; Boecker and Buerger, 2003; Boecker et al., 2018). Less than 5% of the mam-
mary basal cells represent mammary stem cells that express CK5 without luminal epithelial (LE) markers
CK8/18/19 or myoepithelial (ME) marker a-SMA (Böcker et al., 2002; Fu et al., 2020). Expression of CK5 is
also detected in the progenitor cells that can differentiate into mature luminal or ME cells, lacking the
expression of CK5 (Böcker et al., 2002; Boecker and Buerger, 2003; Boecker et al., 2018). Additionally, pro-
genitor cell activity has been attributed to cells expressing CK14 simultaneous with LE or ME markers
(Arendt et al., 2014; Boecker et al., 2018; Fridriksdottir et al., 2017; Villadsen et al., 2007). While CKs are fila-
ment-forming proteins that mechanically support the cell structure, they have also been attributed to other
regulatory functions, such as coordination of nuclear morphology, cell proliferation and apoptosis (Bozza
et al., 2018; Iyer et al., 2013; Pan et al., 2013; Weng et al., 2012). Whether basal CK5 has other than structural
roles in mammary stem and progenitor cells has not been assessed.
Stem or progenitor cells have been suggested to act as targets for neoplasia initiating transformation
(Jiang et al., 2010; Molyneux et al., 2010; Reya et al., 2001). Most mammary carcinomas represent malignant
intraductal hyperplasia of epithelial cell origin. Non-invasive and invasive intraductal proliferative lesions
are distinguished. Non-invasive lesions comprise usual ductal hyperplasia (UDH), atypical ductal hyperpla-
sia (ADH) and ductal carcinoma in situ (DCIS) (Schnitt et al., 2012). Long-term follow-up studies have showniScience 24, 102413, May 21, 2021 ª 2021 The Author(s).





Articlethat in time DCIS cases without treatment may develop into invasive carcinomas andmay eventually lead to
distant metastasis. The percentage of transformed cases varies amongst others according to follow-up
time and grade of lesion, with values for low-grade ranging between 18 and 50%, for intermediate grade
between 32 and 33% and for high-grade between 17.6 and 67%, respectively (Collins et al., 2005; Maxwell
et al., 2018; Ryser et al., 2019; Sanders et al., 2005, 2015). The invasive stage is determined when the bound-
ary provided by ME cells and BM is disrupted. Therefore the ME cell layer has been suggested to act as a
barrier against invasion.
During the neoplastic transformation, mammary epithelial cells undergo alterations in their gene expres-
sion patterns (Allinen et al., 2004). Unfortunately, it has not been possible to identify distinct markers to pre-
dict this transformation from in situ to invasive disease (Yeong et al., 2017). DCIS-associated ME cells
display immunophenotypic differences in comparison to ME cells surrounding normal structures. Several
markers, such as basal CKs, a-SMA, SMMHC, calponin, p63, p75, maspin, WT-1, and CD10 have been
demonstrated to decrease prior to the invasive stage (Chocteau et al., 2019; Guelstein et al., 1993; Hilson
et al., 2009; Kalof et al., 2004; Rohilla et al., 2015;Werling et al., 2003; Wetzels et al., 1989; Zhang et al., 2003).
A sequential disappearance has been shown for p63, calponin, and a-SMA. The loss of a-SMA expression is
linked to later events, and taking place just before invasion (Russell et al., 2015). Recently, loss of a-SMAwas
also shown to compromise the barrier made by ME cells (Sirka et al., 2018), suggesting that the ME layer
acts as a mechanical barrier and that the contractile potential, mediated by a-SMA, is important for its pro-
tective function. Besides displaying physical hindrance, ME cells are known to participate in the production
of BM and regulation of matrix metalloproteinases, further supporting their importance against invasion
(Gudjonsson et al., 2002; Jones et al., 2003; Sánchez-Céspedes et al., 2016; Sarper et al., 2017). Alterations
in DCIS-associated ME cells have been demonstrated by gene expression profiling (Allinen et al., 2004).
However, the mechanisms behind the disruption of the ME layer during malignant progression are not
well understood.
To better understand the role of an intact ME cell layer and mechanisms behind its maintenance, we have
utilized a comparative canine mammary tumor model for human breast carcinomas. Canine and human
mammary tumors share similarities in their epidemiology, etiology, histomorphology, biological behavior,
andmolecular biology. In addition, most mammary carcinomas in humans and canines represent malignant
hyperplasias of ductal epithelial cells (Goldschmidt et al., 2011; Klopfleisch et al., 2011; Rasotto et al., 2014;
Rivera and von Euler, 2011; Sorenmo et al., 2011; Uva et al., 2009). Using immunohistochemistry, we
compared expression patterns of basal/ME markers in untransformed canine mammary tissue sections
with non-invasive intraductal epithelial proliferative lesions of UDH, ADH, and DCIS. We observed that
in the basal/ME cells the expression of cytoskeletal proteins a-SMA, CK5, and CK14 slightly responded
to intraductal proliferations according to the ductal segment and type of proliferative lesion. At the invasive
stage, the expression of these specific markers was absent, coinciding with the disruption of the intact ME
cell layer. Furthermore, our cell biological experiments with primary canine mammary epithelial cells and
the human mammary epithelial cell line showed that the loss of CK5, and to a lesser extent CK14, from the
basal progenitor population affected maturation of the progenitors into functional, contractile ME cells.
Simultaneously, a differentiation bias toward the luminal epithelial cell type was detected with loss of
normal 3D mammosphere morphology and reduction in the basement membrane protein laminin-5.
Importantly, loss of CK5 was associated with downregulation of transcriptional repressor Zinc finger protein
SNAI2 (SLUG), an important regulator of the mammary epithelial cell lineage determination. In conclusion,
our data suggest that CK5 impacts lineage specific differentiation and in this way may direct the formation
of a normal ME layer, subsequently affecting the maintenance of a normal BM layer and mammary organo-
structural homeostasis. Hence, our findings expand our understanding of the carcinogenetic mechanisms
at the pre-invasive stage and the development of phenotypic heterogeneity in mammary carcinomas.RESULTS
Basal/myoepithelial markers CK5, CK14 and a-SMA display specific expression patterns
according to ductal segment and type of intraductal hyperplasia
In women and female canines, invasive mammary carcinomas have been proposed to originate from the
terminal duct lobular unit (TDLU). The TDLU comprises a lobule with acini (terminal ductules) and intralob-
ular terminal duct together with an extralobular terminal duct, which drains into a larger interlobular duct
(Figure S1A). In these structures, ME cells display spatial differences in their morphology and immunophe-




Article2004; Chocteau et al., 2019; Hilson et al., 2009; Rønnov-Jessen et al., 1996; Russell et al., 2015; Sánchez-Cés-
pedes et al., 2016).
To establish these observations quantitatively, we first determined the 3.30-diaminobenzidine-tetrahydro-
chloride (DAB) chromogen staining intensity (DABi) values for the basal/myoepithelial markers CK5, CK14
and a-SMA from normal intralobular terminal ductal segments and extralobular terminal/interlobular
ductal segments using scanned immunohistochemical canine mammary tissue serial sections (Figures
S3A and S3B). Slight but statistically significant difference was observed between the ductal segments
for a-SMA, with normal intralobular terminal ducts showing lower DABi values in comparison to extralob-
ular terminal/interlobular ductal segments. However, the DABi values for CK5 and CK14 were not statisti-
cally significant between different segments (Figure S1B). Hence, our data demonstrate quantitatively that
the expression pattern of basal/ME marker a-SMA differs in a spatial manner in the normal ductal
segments.
a-SMA, CK5, and CK14 are known to be lost from the basal/ME layer prior to the invasive stage (see e.g.
Rohilla et al., 2015; Russell et al., 2015; See also Figure 1A for a-SMA example). To evaluate how the expres-
sion of these proteins is altered with an increasing grade of malignancy, we explored the DABi of these
markers in non-invasive intraductal proliferative lesions of UDH, ADH and various grades of DCIS, and
compared them to one another and to the normal ductal segments in the same canine patients (Figures
1B, 1C,S2A, and S2B). This analysis showed that in the extralobular terminal/interlobular ducts, statistically
significant difference can be determined only for CK5 with I-G DCIS values slightly lower than in the corre-
sponding normal ducts (Figure 1C).
In the intralobular terminal ductal segments CK5 exhibited lower values in florid UDH compared to normal
and higher values in I-G DCIS compared to florid UDH. Lower values were determined for a-SMA in normal
compared to I-G DCIS, and in mild-to-moderate UDH compared to I-G DCIS. CK14 values did not show
statistically significant differences (Figure S2B). Taken together, these data show slight spatial differences
in the expression of MEmarker a-SMA between the normal ductal segments. The other comparative results
suggest that cytoskeletal CK5 and a-SMA in the basal/ME layer may respond to non-invasive intraductal
proliferative lesions in a spatial- and lesion-type-dependent manner.Loss of a-SMA, CK5 and CK14 leads to abnormal 3D mammosphere formation
In both humans and canines, CKs 5 and 14 as well as a-SMA are expressed in the mammary basal/ME
layer, but lost upon invasion (see e.g. Rohilla et al., 2015; Russell et al., 2015; Chocteau et al., 2019; Fig-
ure 1A). To understand how the loss of these specific markers would contribute to the properties of the
ME layer and to the overall morphology of mammary epithelial structures, we isolated CD24+ -epithelial
cells with fluorescence-activated cell sorting (FACS) from primary canine mammary organoids (Figures
S3C–S3F). The isolated population comprised of basal and luminal cells (Figure S3G) (Sleeman et al.,
2006). These primary epithelial cells were targeted with CK5, CK14, or a-SMA-specific siRNAs in 3D Ma-
trigel cultures (Figures 2A and S4A). Loss of each of these proteins led to significantly altered mammo-
sphere morphology with a larger diameter (Figures 2A and 2B). Furthermore, we depleted these proteins
from human MCF10A mammary epithelial cells, containing both basal and luminal cell types (Krause
et al., 2008; Bhat-Nakshatri et al., 2010; Sarrio et al., 2012; Liu et al., 2014; Sokol et al., 2015; Qu et al.,
2015; Miller et al., 2018). As these cells in long-term 3D cultures express markers against both luminal
and basal/ME cells and produce laminin-5 to the forming basement membrane (Figures 2C and S4B;
See also refs. Debnath et al., 2003; Gaiko-Shcherbak et al., 2015; Pinto et al., 2011; Qu et al., 2015; Psef-
togas et al., 2020), we found this cell line as a useful model to target basal/ME proteins. Similar to canine
mammary epithelial cells, loss of CK5, CK14, or a-SMA from human mammary epithelial cell cultures by
specific siRNAs led to significantly enlarged mammosphere structures of abnormal morphology (Figures
2D and 2E).
To further explore whether the loss of these specific CKs could affect the morphology of 3D structures by
impacting the epithelial differentiation process, we isolated the CD49f+ EpCAM population (Eirew et al.,
2008; Stingl et al., 2001), enriched for basal progenitors, from the MCF10A cell line (Figures S4C–S4E).
These progenitor cells were targeted by lentiviral-based RNA interference to knock down CK5 and CK14
(Figures S4F, S4G, and S5A). Similar to siRNA experiments these knock down (KD) cells in a 3D environment
formed larger mammospheres with abnormal morphology (Figures 2F,S5B, and S5C). These resultsiScience 24, 102413, May 21, 2021 3
Figure 1. Intraductal hyperplasia in the extralobular terminal duct/interlobular ductal segment is associated with
modest basal myoepithelial response that is lost prior to invasive stage
(A) Loss of myoepithelial cell layer prior to invasive stage. Canine mammary myoepithelial layer visualized with
immunohistochemical staining for a-SMA (red arrows) in normal interlobular duct (left), ductal carcinoma in situ (DCIS;
middle) and invasive ductal carcinoma (IDC; right). Bar 50 mm.
(B) Consecutive canine mammary FFPE tissue sections of normal, mild-to-moderate usual ductal hyperplasia (UDH, mild-
moderate), florid usual ductal hyperplasia (UDH, florid), atypical ductal hyperplasia (ADH), low-grade ductal carcinoma in
situ (L-G DCIS) and intermediate-grade ductal carcinoma in situ (I-G DCIS) were stained using hematoxylin-eosin (HE, far
left) and the basal myoepithelial markers CK5 (middle left), CK14 (middle right) and a-SMA (far right). Representative
images of the lesions are shown. Red arrows indicate basal myoepithelial layer as distinct from intraluminal cellular
hyperplasia. Bar for HE in normal and mild-to-moderate UDH 50 mm, florid UDH 20 mm, ADH/L-G DCIS 50 mm, I-G DCIS
100 mm and in all IHC 10 mm.
(C) Boxplot of the extralobular terminal / interlobular ductal cellular ln-transformed DAB chromogen staining intensity
(DABi) values for normal CK5 n(cells) = 1203, CK14 n = 1469, a-SMA n = 1765; mild-to-moderate UDH CK5 n(cells) = 12,
CK14 n = 12, a-SMA n = 16; florid UDH CK5 n(cells) = 248, CK14 n = 403, a-SMA n = 304; ADH/L-G DCIS CK5 n(cells) = 268,
CK14 n = 383, a-SMA n = 383; I-G DCIS CK5 n(cells) = 203, CK14 n = 258, a-SMA n = 319. Canine patient n = 7. Black middle
line within box represents median. Height of box is interquartile range (IQR), representing 75th and 25th percentiles,
respectively. Whiskers represent the lowest and highest data within the 1.5 x IQR of the lower and upper quartiles,
respectively. Circles represent outliers. Linear mixed model with random intercepts for canine individual and ductal
segment was used. Pairwise comparison over all the individual companions was implemented with Bonferroni’s multiple
comparisons correction. The level of significance was defined as p< 0.05. Only statistically significant mean differences
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Figure 2. Loss of CK5, CK14 or a-SMA affects the homeostasis of mammary epithelial structures
(A) Depletion of primary canine mammary epithelial cells (CD24+) by specific siRNAs against CK5, CK14, and a-SMA in 3D
Matrigel. Two panels of representative bright field images after 2 weeks of culture are shown. Bar 100 mm.
(B) Quantification of canine 3Dmammary organoid diameters from ctrl, CK5-, CK14-, and SMA-depleted samples, related
to Figure 3A.Mean (GSEM) is shown; n(ctrl) = 31, n(CK5 siRNA) = 51, n(CK14 siRNA) = 31, n(a-SMA siRNA) = 33 ***P<0.001
(Mann–Whitney–Wilcoxon rank-sum test).
(C) 3D-structures of MCF10A cells in Matrigel display both luminal and basal markers. Human mammary epithelial cells
were grown for two weeks in Matrigel, fixed with PFA, and stained with specific antibodies against a-SMA, CK5 and CK18.
Phalloidin was used to visualize actin cytoskeleton and DAPI for nuclei. Bar 50 mm.
(D) MCF10A human mammary epithelial cells were depleted for CK5, CK14, and a-SMA by specific siRNAs in 3D Matrigel
cultures. Samples were grown for two weeks and fixed with PFA for analyses. CK5- and CK14-depleted mammosphere
samples were clearly larger than ctrl 3D structures. Bar 100 mm.
(E) Quantification of the 3Dmammosphere diameter from ctrl, CK5- and CK14-depleted samples. Mean (GSEM) is shown;
n(ctrl) = 15, n(CK5 siRNA) = 15, n(CK14 siRNA) = 15; ***P<0.001 (Mann–Whitney–Wilcoxon rank-sum test).
(F) Depletion of CK5 and CK14 from 3D cultures CD49f+ EpCAM/basal progenitor-enriched MCF10A mammary
epithelial cell population. Cultures were maintained for two weeks, after which they were fixed with PFA and stained with
Phalloidin (green) and DAPI (blue). Representative immunofluorescence images of the 3Dmammospheres are shown. Bar
100 mm. See also Figures S3–S5.
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Articleindicate that basal/ME proteins CK5, CK14, and a-SMA are important for the maintenance of normal mam-
mary organomorphology, at least in the utilized in vitro 3D models.
Cytokeratin 5 determines maturation of the myoepithelial cells
CKs play a role in the mechanical resistance of epithelial cells (Sanghvi-Shah and Weber, 2017). In line with
that, we observed a decrease in the elastic modulus of CK5 KD and CK14 KD cells in comparison to control
(CD49f+ EpCAM-/basal progenitor-enriched MCF10A cells) in indentation experiments using an atomic
force microscope (AFM). The elastic modulus histograms could be fitted with three Gaussian distributions,
revealing a different mechanical behavior at distinct indentation spots within the same cell type (Figures
3A–3D). The elastic modulus values at the peaks of each distribution were significantly lower for CK5 KD
and CK14 KD cells when compared with control cells (Figure 3D).
While CK5 and CK14 clearly maintain mechanical properties of the mammary basal/ME layer, it has not
been assessed whether they could have additional regulatory roles in the progenitor cells. To understand
the role of these CKs in the regulation of mammary progenitor cells, we utilized CD49f+ EpCAM/basal
progenitor-enriched MCF10A cells that were depleted for CK5 and CK14, and analyzed the expression
of several markers by Western blotting (WB) and by immunofluorescence (IF) stainings (Figures 3E–3G
and S6A–S6C). The WB results showed that CK5 KD cells, and to a lesser extent CK14 KD cells, displayed
decreased levels of ME cell marker a-SMA, while the luminal epithelial marker CK18 was slightly increased
in CK5 KD cells and the luminal epithelial marker CK19 decreased (Figures 3E–3G and S6A–S6C). Addition-
ally, CK5 KD cells displayed lower levels of ME cell markers vimentin, smooth muscle myosin heavy chain
(SMMHC) and calponin 1 (Figures S6B and S6C). Similar results showing downregulation of vimentin and
a-SMA were obtained by utilizing specific siRNAs against CK5 in MCF10A cell line (Figures 3H and 3I). In
addition, we performed combined CK5/CK14 siRNA experiments, but could not see higher depletion of
a-SMA upon the combined siRNA treatment in comparison to CK5 depletion alone (Figures S6D and
S6E). Interestingly, depletion of a-SMA seemed to reciprocally downregulate CK5 and vimentin, indicating
a feedback loop mechanism in between these proteins (Figures S6F and S6G). These results suggest that
CK5 has a major role in the maturation process of ME cells, the loss of CK5 leading to a differentiation bias
toward the CK18+ luminal epithelial cell type. As CK5 and CK14 are known to heterodimerize, it may also be
possible that the milder impact of CK14 depletion goes through CK5.
Loss of Cytokeratin 5 impairs junctional integrity and affects deposition of basement
membrane proteins
CKs are linked to integrin- and cadherin-based adhesions, and have been associated with regulation of
these cell adhesive structures (Sanghvi-Shah and Weber, 2017). As CK5, and to a lesser extent CK14,
were found to affect the maturation of ME cells, we wanted to assess whether loss of these proteins could
also impact the resistance of the ME layer through cell adhesive structures. The levels of the ME-specific
cell-cell contact proteins Dsg3 and P-cadherin (Daniel et al., 1995; Runswick et al., 2001) were determined
from lysates of both ctrl (CD49f+ EpCAM/basal progenitor-enriched MCF10A cells) and the correspond-
ing CK5 and CK14 KD cell lines (Figures 4A and 4B). Both markers were significantly decreased upon loss of
CK5, while loss of CK14 did not seem to play a role in maintaining their levels (Figures 4A and 4B). More
detailed immunofluorescence analyses of Dsg3-stained fully confluent epithelial monolayers revealed
that Dsg3 partially lost its junctional pattern in CK5-deficient cells and that the cell-cell junctions appeared
less mature, with spiky protrusions (Figures 4C and 4D). In a 3D environment, CK5 KD cells displayed lower
Dsg3-staining pattern, while CK14 KD cells had many randomly localized cells with junctional Dsg3 within
the morphologically abnormal 3D structures (Figure S7A). Staining of luminal marker E-cadherin from 3D
mammospheres was, however, prominent in all samples but the distribution of E-cadherin positive cells
in CK5 and CK14 KD spheroids was clustered and abnormal in comparison to the ctrl 3D mammospheres
(Figures 4E and 4F). As with CK5 loss, slight decrease in Dsg3 and P-cadherin levels was detected upon
a-SMA-depletion by siRNA in MCF10A cells (Figure 4G). These data indicate that CK5 may play a role in
the integrity of ME cell junctions at least through P-cadherin and Dsg3, and that bidirectional signaling
within the basal/ME layer may be important for the overall maintenance of the epithelial cell populations.
As CK5 loss affected cell-cell adhesions, we further studied whether its downregulation would play a role in
the regulation of cell-substrate adhesions. Immunofluorescence stainings with vinculin antibody in ctrl
(CD49f+ EpCAM/basal progenitor-enriched MCF10A cells) or CK5-deficient cells showed slightly more
prominent vinculin-based cell-substrate adhesions, while vinculin at the cell-cell contacts was showing6 iScience 24, 102413, May 21, 2021
Figure 3. Loss of CK5 affects maturation of myoepithelial cells
(A–C) Elastic moduli of cells determined in cell indentation experiments by AFM. Elastic modulus histograms for (A)
Control (CD49f+ EpCAM -enriched basal progenitors from MCF10A cells), (B) CK5 KD cells and (C) CK14 KD cells. The
histograms were fit with 3 Gaussian distributions (black lines). Each Gaussian distribution is shown separately (red, green,
and blue lines).
(D) Elastic modulus values for the peaks of the Gaussian distributions of Control (CD49f+ EpCAM -enriched basal
progenitors from MCF10A cells), CK5 KD, and CK14 KD cells.
(E) Western blot analyses on cell lysates from ctrl and CK5-and CK14-depleted cell lines showed downregulation of
a-SMA, as detected by specific antibody. In contrast, luminal marker CK18 was slightly elevated in the corresponding cell
lysate samples.
(F and G) Quantification of the a-SMA and CK18 Western blot experiments. Mean (GSEM) is shown; n = 3; *P<0.05,
**P<0.01 and ***P<0.001 (paired ttest).
(H) Ctrl siRNA-treated MCF10A cells and MCF10A cells depleted for CK5 siRNA were analyzed in Western blotting by
specific antibodies against a-SMA and vimentin. GAPDH was used as a loading control.
(I) Quantifications of the Western blots, related to Figure 3H. Mean (GSEM) is shown; n = 3; *P<0.05 and **P<0.01 (paired
ttest). See also Figure S6.
ll
OPEN ACCESS
iScience 24, 102413, May 21, 2021 7
iScience
Article
Figure 4. Loss of CK5 affects cell-adhesive structures
(A) Western blot analyses on cell lysates from ctrl and CK5-and CK14-depleted cell lines showed downregulation of Dsg3
and P-cadherin upon loss of CK5 but not CK14. GAPDH is used as a loading control.
(B) Quantification of the Dsg3 and P-cadherinWestern blot experiments, related to Figure 4A. Mean (GSEM) is shown. n =
4 *P<0.05 (paired ttest); n.s.= not significant.
(C) Ctrl (CD49f+ EpCAM, enriched for basal progenitors) and CK5 KD cells were used in immunofluorescence
microscopy of fully-confluent monolayer cultures. Specific antibody against Dsg3 was used. Actin cytoskeleton was
visualized with Phalloidin and nuclei were stained with DAPI. Magnifications of the cell-cell junction areas, indicated with
yellow boxes, are shown below. Bar 20 mm.
(D) Quantification of the colocalization in between Dsg3 and actin at cell-cell junctions. n(ctrl) = 91, n(CK5 KD) = 75. The
amount of colocalization (%) is shown as box plot with inner and outlier points and mean. ***P<0.001 (paired ttest).
(E and F) (E) CD49f+ EpCAM/basal progenitor-enriched MCF10A mammary epithelial cells, CK5 KD and CK14 KD cells
were culture in 3D Matrigel for two weeks, after which they were fixed with PFA and stained with E-cadherin. Nuclei were
visualized with DAPI. Magnifications of E-cadherin stainings in gray scale are shown in panel (E) and full images with the
indicated magnified areas (yellow boxes) are shown below in panel (F). Bar 25 um.
(G) Depletion of a-SMAwas performed with specific siRNAs in MCF10A cultures for four days. Cellular lysates from control
siRNA and a-SMA siRNA treated cells were used in Western blotting and a specific antibody against Dsg3 was utilized.




Articlepunctate, immature type adhesive structures (Figure S7B). As vinculin has an established role in mechano-
transduction (Goldmann, 2016), we tested whether cell-exerted forces would be altered in the CK5 KD pro-
genitor cell lines. Traction force imaging experiments showed an increase in the actomyosin-mediated cell-
substrate forces in both single cells andmonolayers but no changes in the cell doublets (Figures 5, S7C, and8 iScience 24, 102413, May 21, 2021
Figure 5. Loss of CK5 and CK14 impact cellular force production
(A) Traction force microscopy with ctrl, CK5 KD and CK14 KD cell lines showed altered cell-substrate forces upon CK5 and
CK14 depletion. Representative force maps of ctrl, CK5 and CK14 knock-down cells are shown. Bar 20 mm.
(B) Quantification of the traction force microscopy experiments, related to Figure 5A, showed elevated cell-substrate
forces upon loss of CK5 and CK14. Mean (GSEM) is shown. n(ctrl) = 32, n(CK14 KD) = 40, n(CK5 KD) = 33; *P<0.05 (Mann–
Whitney–Wilcoxon rank-sum test).
(C) Representative examples of monolayer force microscopy maps of ctrl, CK5 KD and CK14 KD cell sheets. Bar 40 mm.
(D) Quantification of the monolayer force microscopy experiments, related to Figure 5C, showed elevated cell-substrate
forces upon loss of CK5. Mean (GSEM) is shown. n(ctrl) = 19, n(CK5 KD) = 16, n(CK14 KD) = 16; **P<0.01; n.s= not




ArticleS7D). These results indicate that the lack of CK5 and CK14 may be counteracted by the redistribution of
intercellular forces, and that loss of these cytokeratins may lead to redistribution of cellular forces.
Finally, to reveal whether CK5 could impact the barrier against transformed luminal cells also through base-
ment membrane formation, we stained 3D mammosphere cultures with laminin-5. Fully mature MCF10A
acinar structures in 3D are known to produce laminin-5 to the basement membrane (Gaiko-Shcherbak
et al., 2015). While we detected this layer both in MCF10A and Cd49f+ EpCAM-cultures (Figures S4B
and 6A), CK5 deficient cultures were displaying significantly decreased amounts of laminin-5 around the
spheroids as visualized by the intensity maps of laminin-5-stainings (Figures 6A,6B, andS8A). However,
CK14 KD cultures did not alter significantly from the ctrl cultures. Additionally, decreased levels of lami-
nin-5 were detected in Western blot experiments, performed from CK5 siRNA-treated MCF10A cells (Fig-
ures S8B and S8C). These results act as additional proof for the observations that loss of CK5 not onlyiScience 24, 102413, May 21, 2021 9
Figure 6. Depletion of CK5 affects laminin-5 production and Zinc finger protein SNAI2 (SLUG2) levels
(A) CD49f+ EpCAM/basal progenitor-enriched MCF10A mammary epithelial cells, CK5 KD and CK14 KD cells were
culture in 3DMatrigel for two weeks, after which they were fixed with PFA and stained with laminin-5 (See also Figure S8A).
Intensity maps were created in Fiji. Lineprofiles were drawn from the edge of the spheroid toward the center. 3–5
lineprofiles were drawn on each spheroid for the analyses of laminin-5 intensity.
(B) Peak values on point 3 from lineprofiles were utilized for further analyses. Values for ctrl, CK5 and CK14 peak values
from line profiles are shown in box plots with inner and outlier points and mean. n(ctrl)= 30; n(CK5 KD) = 57; n(CK14 KD) =
33. ***P<0.001 (paired ttest). (ttest, two tailed, equal variance).
(C) Western blot analyses on cell lysates from ctrl and CK5- as well as CK14-depleted cell lines showed downregulation of
SLUG and slight upregulation of E-cadherin upon loss of CK5, as detected by specific antibody. GAPDH was used as a
loading control.
(D) Quantification of SLUG and E-cadherin Western blot experiments. Mean (GSEM) is shown; n = 3; *P<0.05; n.s.= not
significant (paired ttest).
(E) A hypothetical model for the role of CK5 in the differentiation of mammary epithelial cell lineages, possibly through the
regulation of SLUG. Some of the markers involved in this study are shown as examples within specific cell populations.
Note that in the interest of space, several markers are missing from the hypothetical model and that in this study we did
not concentrate on the expression pattern of these markers in distinct differentiation phases of the mammary epithelial
cell populations. See f.i. Böcker et al. (2002); Boecker and Buerger (2003); Villadsen et al. (2007); Boecker et al. (2018); Fu
et al. (2020) for such studies. See also Figure S8.
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Articleimpacts the mechanical features of the basal layer but also leads to loss of protective basement membrane
possibly through impaired maturation of myoepithelial cells.
Loss of CK5 leads to downregulation of SLUG
To further assess the mechanisms through which CK5 and CK14 could impact the differentiation of mam-
mary epithelial cells, we analyzed the levels of SLUG, a master regulator of themammary epithelial cell line-
age determination and normal tubulogenesis (Nassour et al., 2012; Phillips et al., 2014). In CK5, and to a
lesser extent in CK14-deficient cells, SLUG was downregulated (Figures 6C and 6D). In line with these ob-
servations, the level of E-cadherin, a known target for SLUG-mediated repression (Bolós et al., 2016), was
slightly upregulated upon depletion of CK5 (Figures 6C and 6D). Furthermore, depletion of CK5 by specific
siRNAs from MCF10A mammary epithelial cells led to similar results and, additionally, loss of a-SMA by
siRNA had an almost equal impact (Figures S8D–S8F), again indicating reciprocal regulation within the
basal cell populations. It should be noted that long-term downregulation of CK5 in cell culture conditions
leads to upregulation of some other cytokeratins, including CK6, indicating that loss of CK5 is compen-
sated through an alternative mechanism. This is supported by the re-induction of the studied myoepithelial
markers and upregulation of several cytokeratins in the long-passaged cell clones (Figure S9).
These data indicate that the loss of CK5 may lead to differentiation bias in the mammary progenitors
through regulation of SLUG levels. How specifically CK5 impacts SLUG levels, needs to be assessed in
future studies. A hypothetical model for CK5 in the regulation of mammary epithelial lineage differentiation
and formation of an intact, functional ME layer is presented in Figure 6E.
DISCUSSION
Mammary myoepithelial cells are important for normal mammogenesis and organostructural homeostasis,
and have additionally been shown to have tumor suppressive properties (Gudjonsson et al., 2002; Jones
et al., 2003; Polyak and Hu, 2005; Sánchez-Céspedes et al., 2016). Absence of ME cells and BM penetration
determines stromal invasion, and a gradual loss of ME markers has been suggested to concur with malig-
nant transformation of intraductal epithelial cells with subsequent breakdown of the protective ME barrier
(Hilson et al., 2009; Kalof et al., 2004; Rohilla et al., 2015; Russell et al., 2015; Werling et al., 2003; Zhang
et al., 2003). However, the molecular mechanisms behind the maintenance of this suggested myoepithelial
barrier function are still poorly understood.
In this study, our goal was to understand in more detail the mechanisms leading to compromised ME barrier
function. For this, we used a comparative canine model with immunohistochemical serial stainings for CK5,
CK14, and a-SMA. With these markers we were able to demonstrate some alterations in the basal/ME layer,
in non-invasive intraductal proliferations of increasing grade of malignancy (UDH, ADH/L-G DCIS, I-G DCIS)
by quantitatively determining their DAB chromophore staining intensity values in the TDLU and efferent inter-
lobular ducts (Figures 1CandS2B).Of thesemarkers, onlya-SMAdisplayed spatially statistically different expres-
sion patternswithin the normalmammary ductal segments (Figure S1B). This result is in linewith previous reports
which have made semi-quantitative estimates on differences between the lobular alveolar/ductal and extralob-
ular ductal compartments in the expression of some basal/ME markers in normal human mammary epithelium
(e.g. Chen et al., 2015; Foschini et al., 2000; Pusztaszeri, 2010). This observation is possibly connected to the
compartmentalization of the mammary epithelial structures into the intralobular functional alveolar and prolifer-
ative ductal zones and the extralobular efferent ductal system (Böcker et al., 2002; Rønnov-Jessen et al., 1996;
Pusztaszeri, 2010). The impact of the differential composition of the surrounding intra- and extralobular stromal
tissue on the segment-specific expression pattern should be further investigated.
Furthermore, we showed that the expression patterns of CK5 and a-SMA of the basal/ME layer in the canine
intralobular terminal ductal segments and the extralobular terminal/interlobular ductal segments undergo
modest changes upon non-invasive intraductal proliferations (Figures 1C and S2B). In the extralobular ter-
minal/interlobular ductal segment, the expression of these markers appears to slightly decrease already in
the intermediate-grade DCIS prior to the invasive stage and is eventually lost at invasion (Figures 1A–1C).
What is the biological significance or whether the cytoskeletal markers respond to non-invasive intraductal
epithelial proliferations needs further studies.
a-SMA is lost from the basal/ME layer prior to invasion (Russell et al., 2015). A recent study suggested that




Articlefunction of ME cells against an invasion of transformed epithelial cells (Sirka et al., 2018). Our experiments
showed that depletion of a-SMA from the basal layer in 3D cultures led to abnormalmammospheremorphology
(Figure 2), supporting the observation that contractility andmechanical features of theME layer are crucial for the
maintenance of normal mammary organostructure. Interestingly, loss of CK5 and CK14 from the basal layer re-
sulted in similar, abnormally large and irregular 3Dmorphology (Figures 2, S5B, and S5C). Since cytokeratins are
important for the mechanical features of epithelial cells, as also shown in our cell indentation experiments (Fig-
ures 3A–3D), KD of CK5 andCK14 could lead to abnormal compliancy of the basal layer and in this way advance
such drastic morphological defects in the 3D mammospheres.
CK5 and CK14 are expressed in mammary stem and progenitor cell populations (Böcker et al., 2002; Boecker
et al., 2018; Lee et al., 2012; Villadsen et al., 2007). However, their functions in the progenitors are not properly
understood. Here, we show that KD of CK5, and to a lesser extent of CK14, affected the lineage commitment of
the mammary progenitors: CK5-depleted CD49f+ EpCAM/basal progenitor-enriched cells showed impaired
maturation into contractile ME cells, which was indicated by lower levels of a-SMA, vimentin, SMMHC and cal-
ponin 1, and a concurrent increase in the expression of CK18 (Figures 3 and S6). Loss of CK14 had in our studies
only a slight effect on theseME cell markers (Figures 3 andS6) and, as it is known to heterodimerize withCK5, this
slight effect could possibly also go through CK5.
Additionally, ME-specific cell-cell junction proteins P-cadherin and Dsg3 were downregulated upon loss of
CK5, causing deficiency in the maintenance of intact epithelial structures (Figure 4). Spatially selective
expression of P-cadherin in mammary ME layer is required for the integrity of epithelial tissues and normal
mammary architecture, and it has been shown that KD of P-cadherin from the ME cells compromises the
barrier function of this cell layer (Idoux-Gillet et al., 2018; Sirka et al., 2018; Vieira et al., 2014). Furthermore,
Dsg3 has been shown to co-localize with CK5 and CK14 and is linked to mechanotransduction through E-
cadherin complex, indicating a role for this cell junction protein both in themaintenance of epithelial integ-
rity and in adjustment of mechanical resistance in response to increasing external forces (Uttagomol et al.,
2019; Vielmuth et al., 2018). Loss of CK5 from the basal progenitors thus affects the compliance, contrac-
tility, and integrity of the epithelial junctions, clearly leading to loss of ME barrier function. Interestingly,
loss of a-SMA from the ME cells also led to downregulation of CK5, vimentin, and Dsg3, indicating a reg-
ulatory feedback loopmechanism in between CK5 positive stem/progenitor cells andmatureME cells (Fig-
ures 4G,S6F and S6G). Furthermore, as CK5 KD led to impaired production of basement membrane protein
laminin-5 around the 3D mammospheres (Figures 6A,6B, and S8A–S8C), the results indicate that CK5 not
only impacts the mechanical features of the basal layer but also affects barrier function through the regu-
lation of basement membrane, which is deposited by mature myoepithelial cells.
As a-SMA has been suggested to be the main protein to mediate the contractile potential of ME cells
(Haaksma et al., 2011), we expected that loss of the mature ME cell phenotype would lead to a cell type
which exerts less forces on its environment. However, actomyosin-mediated cell-substrate forces were
slightly increased, as detected by traction force microscopy with single cells and also with monolayers (Fig-
ures 5,S7C, and S7D). This may be explained by the lower levels of these specific cytokeratins as well as the
subsequent lower levels of vimentin, since intermediate filaments have been indicated to play a role in the
co-regulation of actomyosin forces through their association with cell adhesion sites (Bordeleau et al., 2010,
2012; Jiu et al., 2017). The KD phenotype could thus exert uncontrolled forces on the underlying substrate.
Alternatively, weakened cell-cell junctions and the appearance of more prominent cell-substrate adhesions
in the KD cell lines could result in redistribution of cellular forces more toward the underlying substrate.
Whether this has an impact on cellular motility needs to be further assessed in the future.
Finally, the loss of mature ME cell phenotype upon CK5 KD was associated with slightly higher expression
of luminal marker CK18 (Figures 3 and S6), indicating a differentiation bias towardthe luminal cell type.
CK5-deficient cells also expressed significantly lower levels of the transcriptional repressor SLUG (Figures
6C, 6D, and S8D–S8F). SLUG has been shown to determine the lineage specific differentiation of mammary
epithelial cells and is co-localized in a subpopulation of basal cells together with CK5, P-cadherin, and
CD49f (Nassour et al., 2012). In line with our observations, SLUG-deficient cells have been shown to over-
express higher levels of markers linked to luminal lineage, such as CK8, CK18, and ER (Nassour et al., 2012).
SLUG-deficient adult mice display abnormal mammary epithelial cell lineage differentiation with increased
expression of luminal markers in the basal layer and hyperplasia of luminal cells (Phillips et al., 2014). Sup-




Articleexpression of CK18 (Figure 3). In breast cancer, increased CK18 expression has been linked with inhibition
of apoptosis, increase in the expression of CK8 and adhesion proteins as well as decrease in vimentin levels
(Aiad et al., 2014; Bozza et al., 2018; Bühler and Schaller, 2005; Iyer et al., 2013; Schaller et al., 1996; Weng
et al., 2012). Moreover, we observed that E-cadherin, a target for SLUG-mediated repression (Bolós et al.,
2016), was upregulated upon depletion of CK5 (Figures 6C,6D,S8D, and S8E). CK5 KD cells were also
growing slower and a similar phenotype has been observed in SLUG-deficient cells (Nassour et al.,
2012). As SLUG clearly plays a role in the maintenance of basal-like state and represses luminal lineage dif-
ferentiation, loss of CK5 could conceivably cause the differentiation bias via regulation of SLUG. The exact
mechanisms through which CK5 impacts SLUG levels needs to be further studied in the future.
In conclusion, our findings support the previous studies that have underlined the importance of basal myoepi-
thelial cell layer as a barrier that is eventually lost prior to the invasive stage.Our data showed that CK5 loss plays
a major role in the disruption of this myoepithelial layer leading to defects in basement membrane formation.
Downregulation of CK5 and consequent loss of SLUG led to epithelial cell differentiation bias with subsequent
defects in the maturation of myoepithelial cells and a shift toward the CK18-positive luminal epithelial cell type.
The reciprocal interactions of these proteins should also be assessed in more detail in the future.LIMITATIONS OF THE STUDY
Although this study shows an interesting link between cytokeratin 5 and SLUG expression, possibly playing
a role in the differentiation of specific mammary epithelial cell populations, this work does not provide any
information on the molecular mechanisms behind this interconnection. The role of CK5 in the regulation of
SLUG levels clearly needs further studies in the future. Also, the technical challenges in the 3D mammo-
sphere antibody-stainings limited these studies. Furthermore, the amount of canine patient samples,
related to Figure 1, was very limited.Resource availability
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TRANSPARENT METHODS 32 
 33 
Histological samples of canine mammary tissues 34 
Formalin-fixed paraffin-embedded tissue samples of female canine mastectomy cases (n = 7) with 35 
non-infiltrative intraductal proliferative lesions were retrieved from the pathologic-diagnostic archive 36 
(Section of Veterinary Pathology, University of Helsinki). Normal mammary gland from the same 37 
individual was prerequisite. Respective epidemiological data such as breed, sexual status and age at 38 
diagnosis were collected (Fig. S2A). 39 
Histomorphology was reviewed from 4 μm thick hematoxylin and eosin stained tissue sections. 40 
Classification criteria of woman for usual ductal hyperplasia (UDH), atypical ductal hyperplasia 41 
(ADH) and ductal carcinoma in situ (DCIS) were adopted for canine female non-infiltrative 42 
intraductal proliferative lesions (The Consensus Conference Committee, 1997; Collins et al., 2012; 43 
Ferreira et al., 2012; Goldschmidt et al., 2011; Mouser et al., 2010; Schnitt et al., 2012b; Simpson et 44 
al., 2012). Canine lesions classified as ductal displayed E-cadherin positivity, and invasion was 45 
determined as absence of myoepithelial cells and/or extension through the basement membrane 46 
(Chocteau et al., 2019; Goldschmidt et al., 2011; Ressel et al., 2011; The Consensus Conference 47 
Committee, 1997). Canine UDH applied to intraductal proliferation of small epithelial cells with 48 
hyperchromatic nuclei, scant cytoplasm and little nuclear or cellular pleomorphism. 49 
Subcategorization as mild, moderate or florid based on the amount of hyperplastic cells forming 50 
epithelial bridges and irregular fenestrations filling the ductal lumen. The intraluminal cells displayed 51 
positivity for low and/or high molecular weight cytokeratins. Lesions with increased cellular atypia 52 
corresponding to low-grade DCIS, but with only partial involvement of the ductal lumen and limited 53 
extension classified as ADH. DCIS applied to intraductal epithelial proliferations of increasing 54 
cellular atypia allowing categorization into low, intermediate and high nuclear grade DCIS. 55 
 56 
Tissue section immunohistochemistry  57 
Formalin-fixed paraffin-embedded female canine mammary tissue samples were prepared into 4 µm 58 
thick serial sections on Menzel Superfrost Plus Adhesion microscope slides (Cat. J1800AMNZ, 59 
Thermo Fisher Scientific) and baked at 37 °C o/n. The slides were deparaffinized and rehydrated 60 
automated (Leica AutoStainer XL, Leica Biosystems) in xylen and alcohol series before antigen 61 
retrieval in a PT Module (LabVision UK Ltd) for 20 min at 99 °C in prewarmed 0.01 M citrate buffer 62 
(pH 6.0). After cooling down to RT, the slides were blocked 10 min with 3% hydrogen peroxide in 63 
PBS, and rinsed twice with TBS + Tween (Cat. P1379, Sigma). For staining, the BrightVision Poly-64 
HRP-Anti Ms/Rb/Rt IgG Kit (Cat. DPVO110HRP, Immunologic) was used at RT with minor 65 
 
modifications to manufacturers protocol. Primary mouse antibodies were incubated 1 h at RT and 66 
include anti-CK5 (Clone XM26, Cat. 17130, Abcam, dilution 1:75), anti-CK14 (Clone LL002, Cat. 67 
7800, Abcam, dilution 1:300), anti-CK18 (Clone Ks18.04, Cat. 61028, Progen, dilution 1:300), anti-68 
α-SMA (Clone 1A4, Cat. M0851, Dako, dilution 1:600) and primary rabbit anti-E-cadherin (Clone 69 
24E10, Cat. 3195, Cell Signaling Technology, dilution 1:500). For visualization, 3.3´-70 
diaminobenzidine-tetrahydrochloride (Cat. VWRKBS04-110, Immunologic) was applied for 5 min. 71 
Harris Hematoxylin (Cat. HX57998853, Merck) was used for 10 sec to counterstain. The slides were 72 
dehydrated and mounted with Pertex (Cat. 00811, Histolab). To ensure equal preparation and staining 73 
conditions for all the tissue slides, the protocol was implemented on as one batch in one same run. 74 
Adjacent normal tissue was internal positive control. From negative controls the antibody was omitted 75 
and antibody diluent only was used. Stainings were performed twice. 76 
 77 
 78 
Determination of cellular DAB chromogen precipitate intensity 79 
For determination of color-intensity of basal myoepithelial cytoplasmic 3.3´-diaminobenzidine-80 
tetrahydrochloride chromogen precipitate (i.e. DAB staining intensity, DABi), digital images were 81 
generated from IHC stained (α-SMA, CK5 and CK14) female canine mammary tissue slides using a 82 
Pannoramic 250 FLASH II digital whole-slide scanner (3DHISTECH Ltd., Budapest, Hungary) with 83 
a VCC-FC60FR19CL camera (CIS Corporation, Japan) and LS-6 pulsed Xenon light source 84 
(Excelitas Technologies Corp., Waltham, MA, USA). Extended focus was applied with the following 85 
settings: Focus distance field of views: 8; Focus levels: 7; Step size (0.2 µm): 5. Resolution of the 86 
scanner was 0.24 µm/pixel with a 20x/NA 0.8 objective. To ensure subjection to same imaging 87 
conditions, tissue slides were scanned as one batch. For analysis, representative areas of the features 88 
(normal, UDH, ADH, DCIS) from each case were imaged at 69.12x magnification using the 89 
Pannoramic Viewer Software version 1.15.4 (3DHISTECH Ltd., Budapest, Hungary). 90 
Using Fiji ImageJ Software version 1.51 (U. S. National Institutes of Health, Bethesda, Maryland, 91 
USA) the blue wavelength band was separated from TIFF (Tagged Image File Format) image and 92 
inverted to 8-bit resolution grey-scale image with intensity values ranging from 0 = black to 255 = 93 
white. DABi was determined from individual basal/myoepithelial cells by freehand drawing the 94 
boundary of each individual cellular cytoplasmic area (i.e. region of interest, ROI) to be quantified. 95 
Inclusion criteria for cells to be analyzed included basal location between the basement membrane 96 
and the luminal epithelial cell layer as well as the presence of a nucleus. Manual work allowed 97 
precision excluding from the analysis such features as cellular nuclei, overlapping cells and cellular 98 
areas showing only cytoplasm without nuclei as well as other positive reactions for the given antibody 99 
 
(e.g. for α-SMA adjacent myofibroblasts and blood vessels) which would otherwise interfere with the 100 
results. DABi was collected as integrated density value, being the product of ROI area and mean pixel 101 
value. Mean pixel value is determined as the sum of the grey values of all the pixels in the ROI 102 
divided by the number of pixels. DABi values from the intralobular terminal ductal and the 103 
extralobular terminal ductal/interlobular ductal segments were collected and analyzed as distinct 104 
entities according to their anatomical and physiological differences (Rønnov-Jessen et al., 1996). The 105 
used protocol is summarized in Fig. S3B. 106 
 107 
  108 
Isolation of canine mammary primary organoids  109 
Canine normal mammary tissue samples (c. 5 x 10 mm) were collected aseptically into DMEM/F12 110 
medium (Cat. 31330-038, Gibco) from removed tissue (sterilized female, 9 years-of-age, mixed breed 111 
of Belgian Sheepdog and German Shepherd Dog) at canine mammary gland surgery (Veterinary 112 
Teaching Hospital, University of Helsinki), and kept at 4 °C until macrodissection to remove adherent 113 
fat and surplus stroma (LaBarge et al., 2013). The medium was supplemented with 0.25 μg/ml 114 
Amphotericin B (Cat. A2942, Sigma), 100 U/ml Penicillin and 100 μg/ml Streptomycin (Cat. 15140-115 
122, Gibco) as well as 10% FBS (Cat. 10500-064, Gibco). Mammary tissue next to the area of sample 116 
origin was collected simultaneously into 10% neutral-buffered formalin to confirm histomorphology. 117 
After macrodissection, the remaining tissue was cut into 3-4 mm slices for digestion in pre-warmed 118 
(37 °C) DMEM/F12 medium supplemented with antibiotica and FBS (as above), 10 μg/ml Insulin 119 
(Cat. I6634, Sigma), 200 U/ml Collagenase (Cat. C0130, Sigma), and 100 U/ml Hyaluronidase (Cat. 120 
H3506, Sigma) with o/n incubation in a 37 °C water bath using gentle agitation. Digestion was 121 
monitored by microscopy using a camera (Canon EOS 600D) attached to an inverted microscope 122 
(Olympus CKX41). 123 
Digested material was centrifuged at 600 x g 5 min to separate remaining fat etc. (LaBarge et al., 124 
2013). A 40 μm cell strainer was used to collect the size-differentiated organoid fractions. Media 125 
supplemented with antibiotics and FBS (as stated above) was applied for rinsing. The collected 126 
material was pelleted at 80 x g 30 s and aliquoted into freezing medium of 50% DMEM/F12 plus 127 
44% FBS plus 6% DMSO (Cat. D2650, Sigma) (StemCell Technologies, 2012) and stored at -130 128 
°C until fluorescence-activated cell sorting (FACS). 129 
 130 
Fluorescence activated cell sorting of canine mammary epithelial cells  131 
For FACS, the canine organoid fractions were incubated at 37 °C in a humidified 5% CO2 cultivator 132 
in DMEM/F12 supplemented with antibiotica and FBS (as stated above), 15.0 µg/ml Insulin (Cat. 133 
 
I6634, Sigma), 10.0 ng/ml EGF (Cat. E9644, Sigma) and 0.6 µg/ml Hydrocortisone (Cat. H0888, 134 
Sigma) for 2-3 d. Differential trypsinization to remove fibroblasts was applied prior generating single-135 
cell suspension for FACS (LaBarge et al., 2013). Single cell suspension of 1x106 cells/ml was 136 
generated into HBSS + 1% BSA from canine primary culture using incubation with TrypLE Express 137 
(Cat. 12604-013, Gibco) and DNase I (Cat. 11284932001, Roche). Cells were incubated with anti-138 
CD24-Alexa Fluor 405 (Clone ML5, Cat. NB100-77903AF405, Novus Biotechne, 0.7mg/ml) at 4 °C 139 
for 45 min in the dark and washed with HBSS + 1% BSA three times. After the last wash, the cells 140 
were re-suspended into 500 μl FACS-buffer consisting of PBS + 0.5% BSA followed with a 10 min 141 
incubation with a live/dead discriminating stain (Cat. L34975, Invitrogen/Thermo Fisher Scientific). 142 
A FACSAria II (BD Biosciences) instrument was used to sort the cells with red (633 nm) and violet 143 
(405 nm) lasers at sheat pressure 45.00 and with a 85 µm nozzle. The data was collected using the 144 
FACSDiva Software version 8.0.2 (BD Biosciences). Dead cells, non-single cells and CD24neg cells 145 
were excluded. The cells were isolated into growth medium (as stated above) in tubes coated by 146 
incubation with HBSS + 3% BSA for 2 h under UV-radiation at RT. To determine the sorting purity, 147 
the isolated cell population was stained for immunofluorescence imaging prior downstream assay 148 
(Fig. S2F). FACS data was analyzed and the graphs generated with the FlowJo Software version 149 
10.4.1 (BD Biosciences). 150 
 151 
Cell culture and siRNA transfections 152 
Human breast epithelial cell line MCF10A cells (ATCC) were maintained in DMEM/F12 media 153 
supplemented with 5% Horse Serum (Cat. 26050088, Gibco), 20 ng/ml EGF (Cat. E9644, Sigma), 154 
0.5 mg/ml Hydrocortisone (Cat. H0888, Sigma), 100 ng/ml Cholera toxin (Cat. C8052, Sigma), 10 155 
µg/ml Insulin (Cat. I6634, Sigma) and 100 U/ml Penicillin and 100 μg/ml Streptomycin (Cat. 15140-156 
122, Gibco). Cells were cultured in an incubator with 5% CO2 at 37 °C. 157 
For siRNA transfections in 2D, MCF10A cells were plated on 35 mm dishes at a density of 5000 cells 158 
per well. The following day, cells were transfected with 50 nmol siRNA (human CK5: ON-159 
TARGETplus KRT5 SMART pool siRNA [L-011067-00-0005]; human CK14: ON-TARGETplus 160 
KRT14 SMART pool siRNA [L-010602-00-0005]; and human SMA: ON-TARGETplus ACTA2 161 
SMART pool siRNA [L-003450-00-0005]; negative control: ON-TARGETplus Non-targeting 162 
siRNA [D-001810-01-05] from Dharmacon) using Ribojuice siRNA transfection reagent (Cat. 163 
71115-3, Millipore) according to the manufacturer´s instructions. On day 4., cells were processed for 164 
Western blotting or microscopy.  Canine primary cell transfections in 2D conditions were performed 165 
as with human MCF10A cells. For canine cells, pool of custom-made siRNAs were used: canine 166 
CK5: 5’ UAACUCUUGAAACUCUUCCUU 3’, 5’ AACUCUUGAAACUCUUCCGUU 3’, 5’ 167 
 
ACUCUUGAAACUCUUCCGGUU 3’; canine CK14: 5’ UAGUCCUUGGUCUCAGCGGUU 3’, 168 
5’ UCUCAGAGCGUUCAUUUCCUU 3’, UCCACGUUGACAUCUCCGCUU 3’; canine ACTA2 169 
5’ UACUUCAAGGUCAGGAUCCUU 3’, 5’ UCUAUCGGGUACUUCAAGGUU 3’, 5’ 170 
AUGAUGCCGUGUUCUAUCGUU 3’ (Dharmacon). In 3D Matrigel cultures of human and canine 171 
mammary epithelial cells, siRNAs (50 nmol) were applied after formation of mammospheres (day 5) 172 
and incubated for 2 weeks. siRNAs were added to cells every 4 days.  173 
 174 
Fluorescence cell sorting of MCF10A cells 175 
The FACS protocol from Abcam was followed in this experiment. Briefly, the cells were harvested 176 
by trypsinization. Disassociated cells were resuspended at a concentration of approximately 1x106 177 
cells/ml in ice cold PBS, 10% FCS, 1% sodium azide. The cells were fc blocked using Human Fc 178 
block (Cat. 564219, BD Biosciences) following manufacturer’s instructions. To remove unbound fc 179 
block, the cells were washed 3 times by centrifugation at 400 g for 5 min and resuspended in ice cold 180 
PBS. 5 μg/ml of the primary antibodies anti-CD49f-FITC (Clone GoH3, Cat. 561893, BD 181 
Biosciences) and anti-EpCAM-APC/Cy7 (Clone G8.8, Cat. 118217, Biolegend) were added to the 182 
cells and incubated for 1 h at 4°C in the dark. The cells were washed as described in the previous 183 
steps and resuspended in ice cold PBS, 10% FCS, 1% sodium azide. The cell suspension was 184 
immediately stored at 4°C in the dark. The cells were sorted using a FACSAria II (BD Biosciences) 185 
instrument at sheat pressure 45.00 with a 85 μm nozzle and the blue (488 nm) as well as red (633 nm) 186 
lasers. The flow cytometer settings adjustments and subsequent data collection was done using 187 
FACSDiva Software version 6.1.3 (BD Biosciences). Compensation was performed using unstained 188 
cells and single stained control cells. The data generated was analyzed using FlowJo Software version 189 
10.6.1.  190 
 191 
Lentiviral-based RNA interference 192 
Lentiviral RNA interference was done as described in Cattavarayane et al., 2015. The packaging 193 
vector containing the desired shRNA construct was received from SIGMA. The helper plasmids 194 
pMD2.G (Plasmid 12259), and pMDL g/p RRE (Plasmid 12251) and pRSV-Rev (Plasmid 12253) 195 
were provided by Addgene. DNA transfections were performed by using Lipofectamine 2000 196 
(Invitrogen). The packaging vector: pVSVG : pMDL g/p RRE : pRSV-Rev were used in 3:1:1:1 197 
proportion and the total DNA used for transfection was 20 μg (15µg :: 2.5 µg : 830 ng : 830 ng : 830 198 
ng). Nearly confluent (70–80%) 293 T cells were grown on Corning CellBind (Cat. 3296) 6 well plate 199 
for transfections. 24 hrs post transfection, media containing the transfection mix was removed 200 
carefully and 1 ml of fresh media was added. The media supernatant containing the viral particles 201 
 
was collected every 12 hrs for 3–4 days and stored at 4 °C. The viral supernatants were pooled and 202 
centrifuged at 1000 rpm for 5 minutes and filtered through a 0.44 μm filter. The cells were infected 203 
using viral supernatant for 24 hrs in the presence of 4 μg/ml polybrene (Cat. 107689, Sigma) and the 204 
infected cells were selected using puromycin (4 μg/ml, Sigma). The puromycin selected cells were 205 
expanded and stored by freezing in 90% FCS, 10% DMSO (Sigma) at -130 °C. 206 
 207 
Western blotting  208 
Cells were washed with PBS and lysed in 1% Triton X-100/PBS, containing protease and phosphatase 209 
inhibitors (Cat. 539131 and Cat. 539131, Calbiochem). Protein concentrations were measured with 210 
Qubit® Protein Assay Kit (ThermoFisher Scientific). Sample loading buffer, 4x LSB-DTT, was 211 
added to lysates and samples were boiled for 5´ before loading in SDS-PAGE gels (Bio-Rad). Wet 212 
transfer (Bio-Rad) with Immobilon-P Membrane, PVDF filter (Millipore) was used for blotting. 213 
Mixture of 5% BSA and 5% milk was used for blocking for at least 1 h. Following antibodies were 214 
used for detection of specific proteins: mouse anti-CK5 (Clone XM26, Cat. ab17130, Abcam), mouse 215 
anti-CK6 (Clone B-7, Cat. sc-514520, Santa Cruz), mouse anti-CK14 (Clone LL002, Cat. ab7800, 216 
Abcam), rabbit anti-CK18 (Polyclonal, Cat. ab24561, Abcam), mouse anti-CK19 (Clone BA-17, Cat. 217 
ab7755, Abcam), mouse anti-Pan-Keratin (Clone C11, Cat. 4545, Cell Signaling Technology; 218 
Recognizing CK4, 5, 6, 8, 10, 13 and 18), mouse anti-SMA (Clone 1A4, Cat. A5228, Sigma), rabbit 219 
anti-E-cadherin (Clone 24E10, Cat. 3195, Cell Signaling Technology), rabbit anti-P-Thr18/Ser19-220 
MLCII (Clone Thr18/Ser19, Cat. 3674, Cell Signaling Technology), mouse anti-calponin1 (Clone 221 
CALP, Cat. sc-58707, Santa Cruz), rabbit anti-Vimentin (Clone D21H3, Cat. 5741, Cell Signaling 222 
Technology), mouse anti-Dsg3 (Clone 5H10, Cat. sc-23912, Santa Cruz), rabbit anti-P-cadherin 223 
(Clone C13F9, Cat. 2189, Cell Signaling Technology), rabbit anti-Slug (Clone C19G7, Cat. 9585, 224 
Cell Signaling Technology) and mouse anti-GAPDH (Clone GAPDH-71.1, Cat. G8795, Sigma). 225 
Anti-mouse or -rabbit HRP-linked secondary antibodies (Cell Signaling Technology) in 1:3000 226 
dilution and Western HRP substrate (Cat. WBLUR0100, LuminataTMCrescendo, Millipore) were 227 
used for chemiluminescence detection of the protein bands. Images were taken with Fujifilm LAS-228 
3000 Imager using autoexposure-setting that choose the optimal exposure time for each blot. 229 
 230 
Immunofluorescence microscopy  231 
Cells were cultured on coverslips and washed with PBS prior to fixation with 4% PFA. 232 
Permeabilization was performed with 0.1% Triton X-100 in TBS for 5´ and cells on coverslips were 233 
moved to 0.2% Dulbecco/BSA. The following primary antibodies were used for stainings in 1:50 234 
dilutions: mouse anti-CK5 (Clone XM26, Cat. ab17130, Abcam), mouse anti-CK14 (Clone LL002, 235 
 
Cat. ab7800, Abcam), rabbit anti-P-Ser18/Thr19-MLCII (Clone Thr18/Ser19, Cat. 3674S, Cell 236 
Signaling Technologies), rabbit anti-E-cadherin (Clone 24E10, Cat. 3195, Cell Signaling 237 
Technologies), mouse anti-vinculin (Clone hVin-1, Cat. V9264, Sigma), and mouse anti-Dsg3 (Clone 238 
5H10, Cat. sc-23912, Santa Cruz), mouse anti-Laminin-5 (Clone D4B5, Cat. MAB19562, Sigma-239 
Aldrich). Alexa Fluor α-rabbit 488 and α-mouse 568 (Life TechnologiesTM) secondary antibodies 240 
were used to detect the primary antibodies. Actin cytoskeleton was detected with Alexa-488-, -568- 241 
and -647-Phalloidins in 1:200 dilution (Life TechnologiesTM) and DNA with DAPI (Life 242 
TechnologiesTM). DABCO/Mowiol was used for mounting. Images were acquired with Leica 243 
DM6000 and Leica DM5000 upright fluorescence wide field microscopes equipped with a 244 
Hamamatsu Orca-Flash4.0 V2 sCMOS camera.  245 
 246 
3D mammosphere cultures  247 
Matrigel, ECM gel from Engelbreth-Holm-Swarm murine sarcoma (Sigma E1270) was prepared 248 
according to manufacturer’s instructions. MCF10A cells were trypsinized and approximately 5000 249 
cells in F12 media were seeded on top of the Matrigel-coated eight-chamber slides. Formation and 250 
morphology of spheres were monitored frequently under a light microscope. After two weeks, 3D 251 
structures were fixed with 2% PFA and diameter of the structures were calculated from bright field 252 
images using ImageJ. For IF, cells were permeabilized with 0.25% Triton-X in PBS for 10 min. 253 
Unspecific binding sites were blocked with IF buffer (0.1% BSA, 0.2% Triton-X, 0.05% Tween in 254 
PBS) supplemented with 10% goat serum at RT for 1 h. Primary antibodies in blocking solution were 255 
incubated o/n at 4 °C and secondary antibodies at RT for 30 mins.  Cytoskeletal structures were 256 
stained with Phalloidin and nucleus with DAPI. Samples were mounted with Mowiol/DABCO. The 257 
IF stainings of 3D spheroids were performed as in https://brugge.med.harvard.edu/protocols with 258 
minor modifications. Imaging stacks was performed with Leica TCS SP5. Objective used: HCX PL 259 
APO 20x/0,7 Imm Corr (water, glycerol, oil) Lbd.bl. 260 
 261 
Determination of cell elastic modulus by atomic force microscopy 262 
The elastic moduli of MCF10A, CK5 KD, and CK14 KD cells were determined by cell indentation 263 
experiments using a MultiMode 8 atomic force microscope (AFM) with a NanoScope V controller 264 
and a closed-loop PicoForce scanner (Bruker, Santa Barbara, CA). The cells, grown on coverslips 265 
coated with LN111, were mounted in the AFM and indented with triangular MLCT probes (Bruker) 266 
with nominal tip radius of 20 nm and spring constants about 0.05 N/m, obtained by the thermal noise 267 
method (Hutter and Bechhoefer, 1993). The deflection sensitivity was measured on a hard, freshly 268 
 
cleaved mica surface just before the experiments with cells. Cell indentation was carried out with the 269 
AFM operating in Force Volume mode (contact mode), collecting indentation force curves in 40 × 270 
40 µm2 areas, the so-called force maps, which were divided into 16 × 16 pixels. A force curve was 271 
recorded at each pixel of the force map (that is, 256 force curves per force map) by indenting the cells 272 
at 4 µm/s rate, with maximum applied forces typically in the range of 1.0–1.5 nN. The experiments 273 
were carried out in PBS at 37 °C (Thermal Applications Controller, Bruker). The elastic modulus of 274 
the cells were obtained by fitting the approach indentation curves with the Sneddon (conical indenter) 275 
model (Sneddon, 1965), using the software NanoScope Analysis 1.5 (Bruker). Between 440 and 750 276 
indentation curves from 2 or 3 different 40 × 40 µm2 force maps, corresponding to about 8 to 12 277 
cells, were analyzed for each cell type. The indentation depth was typically in the range 1.5 – 2.5 µm. 278 
The corresponding elastic modulus histograms were fit with three Gauss distributions using OriginPro 279 
2020 software. 280 
 281 
Traction force microscopy 282 
For traction force microscopy experiments in the single cell, the cell doublet, or the monolayers, cells 283 
were plated on elastic collagen-1-coated polyacrylamide (PAA) gel substrates with a stiffness 284 
(Young’s Modulus/elastic modulus) of 4 kPa (single cell) or 6.3 kPa (cell doublet) and incubated for 285 
2-4 h prior to imaging. Gel substrates were surface-coated with sulfate fluorescent microspheres 286 
(Invitrogen, diameter 200 nm) before coating with collagen-1. Single cells together with the 287 
underlying microspheres were imaged at multiple locations with 3I Marianas imaging setup 288 
containing a heated sample chamber (37 °C) and controlled CO2 (3I intelligent Imaging Innovations, 289 
Germany). 63x/1.2 W C-Apochromat Corr WD=0.28 M27 objective was used. Following live cell 290 
imaging, the cells were detached from the substrates with 10x Trypsin (Lonza Group) and a second 291 
set of microsphere images was taken to serve as reference images. Displacement maps for 292 
microspheres were achieved by comparing the reference microsphere images to the experimental 293 
images and by knowing the cell-induced displacement field, substrate stiffness (4 kPa), and a manual 294 
trace of the cell boundary, we computed the cell-exerted traction fields by using Fourier Transform 295 
Traction Cytometry (Krishnan et al., 2009; Tolić-Nørrelykke et al., 2002). Root mean squared 296 
magnitudes were computed from the traction fields. For the measurement of intercellular stresses, we 297 
utilized cell doublets. These assays were performed at 6.3 kPa PAA dishes, with an optical resolution 298 





Colocalization analyses 303 
Colocalization of actin (Phalloidin) and Dsg3 at cell-cell junctions was analyzed in Fiji. Manually 304 
drawn areas of cell-cell junctions were used as regions of interest, ROI, and colocalization (in %) on 305 
this region was analyzed with FIJI colocalization analysis.  306 
 307 
Analyses of laminin-5 intensity from 3D spheroids 308 
Raw data images from laminin-5 stainings of 3D mammospheres were imported to Fiji and line 309 
profiles, starting immediately outside the spheroid structures, were drawn towards the cell center (Fig. 310 
6A). 3-5 line profiles were drawn around one spheroid. Intensity maps of the stainings were also 311 
performed to better demonstrate the differences in between samples. Numerical values from the line 312 
profiles were exported to excel. Of these data, the third point from the line profiles mostly displayed 313 
highest intensity values within the studied samples and was chosen for further analysis to compare 314 
the laminin-5 intensities in between different samples/spheroids. t-test (two-tailed, equal variance) 315 
was used to analyse the statistical significance of these peak values in between groups.  316 
 317 
Statistical analysis  318 
Standard deviations and statistically significant difference between means of two groups (t-test) were 319 
analyzed in Microsoft Excel 2013. Mann–Whitney–Wilcoxon rank-sum test was performed with 320 
Origin 2018. For statistical analysis of DAB chromogen staining intensity (DABi), multilevel mixed 321 
linear model was performed using the IBM SPSS Software version 25.0 (IBM Corp., USA). The 322 
fixed main effects of age, gender, DABi biomarker group (i.e. CK5, CK14 and α-SMA), ductal 323 
segment and pathologic-anatomic diagnosis (PAD) on the DABi-values were examined. The DABi 324 
biomarker group, PAD and the interaction between biomarker group and PAD were regarded as fixed 325 
effects. Random intercepts for dog individual and ductal segment (i.e. intralobular terminal duct, 326 
extralobular terminal duct/interlobular duct) were used to account for the hierarchical structure of the 327 
data. Thus, individual basal myoepithelial cells (i.e. observation unit) were nested (clustered) within 328 
ductal segments and ductal segments nested within dogs. DABi-values were ln-transformed for the 329 
statistical analysis due to skewed distribution. Bonferroni’s multiple comparisons correction was used 330 
when comparing more than 2 groups, that is DABi biomarker groups and PAD groups within and 331 
between ductal segments. Pairwise comparison over all the individual companions was implemented. 332 
The level of significant was defined as p < 0.05. No statistical methods were used to predetermine 333 
the DABi biomarker study sample size. 334 
 335 
 




Figure S1: Expression of basal myoepithelial biomarkers in normal mammary ductal segments, 339 
Related to Figure 1. A) Histomorphology of the canine mammary terminal duct lobular unit (TDLU) 340 
consisting of a lobule with acinar units (asterix) and intralobular terminal duct (wedge) as well as 341 
extralobular terminal duct (thin arrow), leading into interlobular duct (thick arrow). Hematoxylin and 342 
eosin (HE) staining. Bar 500 µm. B) Boxplot showing the difference in between the cellular ln-343 
transformed DAB intensity (ln DABi) values for the basal myoepithelial biomarkers CK5, CK14 and 344 
α-SMA in between the normal intralobular terminal ductal segment (CK5 n(cells)=612; CK14 n=816; 345 
α-SMA n=875) and the extralobular terminal / interlobular ductal segment (CK5 n=1203; CK14 346 
n=1469; α-SMA n=1765). Canine patient n=7. Black middle line within box represents median. 347 
Height of box is interquartile range (IQR), representing 75th and 25th percentiles, respectively. 348 
Whiskers represent the lowest and highest data within the 1.5 x IQR of the lower and upper quartiles, 349 
respectively. Circles represent outliers. Linear mixed model with random intercepts for canine 350 
individual and ductal segment was used with Bonferroni’s multiple comparisons correction. The level 351 
of significant was defined as p < 0.05. Only statistically significant mean differences are indicated. 352 
Significant difference was determined between the normal ductal segments in the expression of α-353 





Figure S2. Expression of CK5, CK14 and α-SMA in the intralobular terminal ductal segment 358 
upon intraductal hyperplasia, Related to Figure 1. A) Consecutive canine mammary FFPE tissue 359 
sections of normal, mild-to-moderate usual ductal hyperplasia (UDH, mild-to-moderate), florid usual 360 
ductal hyperplasia (UDH, florid) and intermediate-grade ductal carcinoma in situ (I-G DCIS) were 361 
stained using hematoxylin-eosin (HE, far left) and the basal myoepithelial markers CK5 (middle left), 362 
CK14 (middle right) and α-SMA (far right). Representative images of the lesions are shown. Red 363 
 
arrows indicate basal myoepithelial layer as distinct from intraluminal cellular hyperplasia. Bar for 364 
HE in normal, mild-moderate UDH, florid UDH and I-G DCIS 50 µm, and in all IHC 10 µm. B) 365 
Boxplot of the quantifications of intralobular terminal ductal cellular ln-transformed DAB intensity 366 
(ln DABi) values for normal CK5 n(cells)=612, CK14 n=816, α-SMA n=875; UDH mild-to-moderate 367 
CK5 n=22, CK14 n=17, α-SMA n=29, UDH florid CK5 n=151, CK14 n=203, α-SMA n=258; I-G 368 
DCIS CK5 n=105, CK14 n=184, α-SMA n=153. Canine patient n=7. Black middle line within box 369 
represents median. Height of box is interquartile range (IQR), representing 75th and 25th percentiles, 370 
respectively. Whiskers represent the lowest and highest data within the 1.5 x IQR of the lower and 371 
upper quartiles, respectively. Circles represent outliers. Linear mixed model with random intercepts 372 
for canine individual and ductal segment was used. Pairwise comparison over all the individual 373 
companions was implemented with Bonferroni’s multiple comparisons correction. The level of 374 






Figure S3: Determination of DAB intensity and isolation of epithelial cells for siRNA 379 
experiments from canine mammary gland, Related to Figure 1 and Figure 2. A) Patient data of 380 
canine cases selected for DAB intensity determination of basal myoepithelial markers α-SMA, CK5 381 
and CK14. B) Scheme summarizing the protocol used to determine the DAB intensity (DABi) of 382 
basal myoepithelial markers α-SMA, CK5 and CK14 from canine mammary gland tissue sections 383 
stained with immunohistochemistry. Tissue section scans were generated with a Pannoramic 250 384 
FLASH II digital scanner and features of interest imaged using Pannoramic Viewer. The 8-bit blue 385 
wavelength band image was separated, transformed into greyscale and inverted using ImageJ, 386 
followed by determination of the DABi from freehand-drawn cellular regions of interest (yellow in 387 
image far right). C) Scheme summarizing the protocol used to isolate mammary epithelial cells from 388 
freshly collected canine mammary gland tissue. D-F) FACS isolation strategy of CD24+ canine 389 
mammary epithelial cells showing the proportion of parent cells for each gate. D) Single-cellular 390 
suspension of canine mammary epithelial cells gated for live cells using LIVE/DEAD® Fixable Near-391 
IR Red. E) Doublets and larger cell clumps were discriminated in live cells population. Scatter Gate 392 
display (left), FSC Gate display (middle) and SSC Gate display (right). F) Single-cells gated by 393 
CD24-AF405 for CD24+ population representing epithelial cells. FSC-A = Forward Scatter Area; 394 
SSC-A = Side Scatter Area; FSC-W = Forward Scatter Width; FSC-H = Forward Scatter Height; 395 
SSC-W = Side Scatter Width; SSC-H = Side Scatter Height. G) Immunofluorescence stainings of the 396 
CD24+ -primary canine mammary epithelial cells with specific antibodies against CK14 (red) and 397 




Figure S4: Knock-down of α-SMA, CK5 and CK14 from canine and human mammary 400 
epithelial cells, Related to Figure 2. A) Depletion of primary canine mammary epithelial cells 401 
(CD24+) by specific siRNAs against CK5, CK14 and α-SMA on 2D cell culture conditions. Cellular 402 
lysates were performed 4 days after application of siRNAs and protein levels were assessed in 403 
Western blotting by specific antibodies. GAPDH acts as a loading control. B) MCF10A cells, cultured 404 
for 2 weeks in 3D Matrigel, display hollow lumen and secretion of basement membrane proteins. 405 
Specific antibody against laminin-5 was utilized for PFA-fixed spheroids and Phalloidin was used to 406 
visualize actin cytoskeleton and DAPI nuclei. Bar 50 um. C) FACS-sorted CD49f+ EpCAM- - 407 
mammary epithelial cell population enriched for basal progenitors, isolated from MCF10A cells and 408 
stained with specific antibodies against CK5, CK8, CK14 and vimentin. Nuclei were visualized with 409 
DAPI. Isolated cells display CK5/CK8 double positive cells and cells displaying either CK14 or 410 
vimentin. Bar 20 µm. D) Comparison of parental cell line MCF10A and FACS-sorted CD49f+ 411 
EpCAM-  cell population. Cellular lysates were utilized in Western blotting to assess the levels of 412 
CK5 and CK14. GAPDH acts as a loading control. E) Quantification of CK5, related to Figure S3D. 413 
Mean (± SEM) is shown; n=3; *P<0.05 (paired t-test). F) Lentiviral-based RNA interference was 414 
utilized to deplete CK5 and CK14 from CD49f+ EpCAM- - mammary epithelial cell population 415 
enriched for basal progenitors. Western blotting was used to confirm the efficiency of depletion. 416 
GAPDH was used as a loading control. G) Quantification of the CK5 and CK14 levels from ctrl 417 
(CD49f+ EpCAM-, enriched for basal progenitors), CK5 KD and CK14 KD cells, related to Figure 418 





Figure S5: Depletion of CK5 and CK14 from CD49f+ EpCAM- basal progenitor-enriched 422 
MCF10A mammary epithelial cell population, Related to Figure 2. A) Immunofluorescence 423 
stainings of the created knock down cell lines with specific antibodies against CK5 and CK14. Actin 424 
cytoskeleton was visualized with Phalloidin and nuclei with DAPI. B) Depletion of CK5 and CK14 425 
from 3D cultures of CD49f+ EpCAM- basal progenitor-enriched MCF10A mammary epithelial cells. 426 
Cultures were maintained for two weeks, after which they were fixed with PFA and stained with 427 
Phalloidin (green) and DAPI (blue). Representative immunofluorescence images of two sets of 3D 428 
mammospheres from separate experiments are shown. In the upper panel visualized with Phalloidin 429 
and lower with Phalloidin and DAPI. Bar 100 μm. C) Measurement of spheroids area was performed 430 
with Fiji-ImageJ 1.52p (National Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/, 431 
1997-2019) software using free-hand selection tool and the built-in area measurement function. 432 
***P<0.001 (One-Way ANOVA analysis, Tukey’s post-test. 433 
 
 434 
Figure S6: Depletion of CK5 leads to downregulation of markers for mature myoepithelium, 435 
Related to Figure 2 and Figure 3. A) Immunofluorescence stainings of ctrl (CD49f+ EpCAM-, 436 
enriched for basal progenitors) and CK5 KD cells were stained with specific antibodies against CK5 437 
and -SMA. Nuclei were visualized with DAPI. Bar 20 µm. B) Cellular lysates from ctrl (CD49f+ 438 
 
EpCAM-, enriched for basal progenitors), CK5 and CK14 KD cell lines were utilized in Western 439 
blotting. Specific antibodies against vimentin, calponin 1, smooth muscle myosin heavy chain 440 
(SMMHC) and CK19 were used in blotting. GAPDH was used as a loading control. C) Quantification 441 
of vimentin levels, related to Fig. S5B. Mean (± SEM) is shown; n=3; *P<0.05 (paired t-test); n.s.= 442 
not significant. D) Scrambled siRNA and specific siRNAs against CK5 in combination with CK14 443 
siRNA were utilized in MCF10A cells. Cellular lysates were performed four days after incubation 444 
and protein levels for CK5, CK14, -SMA and P-cadherin were detected in Western blotting with 445 
specific antibodies. GAPDH acts as a loading control. E) Quantification of the -SMA levels showed 446 
significant decrease upon CK5/CK14 depletion. Mean (± SEM) is shown; n=3; *P<0.05 (paired t-447 
test). F) Depletion of -SMA was performed with specific siRNAs in MCF10A cultures for four 448 
days. Cellular lysates from control siRNA and -SMA siRNA- treated cells were used in Western 449 
blotting and specific antibodies against-SMA, CK5 and vimentin were utilized to assess their levels. 450 
GAPDH was used as a loading control. Quantification of the CK5 levels showed significant decrease. 451 
G) Quantification of CK5 levels, related to Figure S5F. Mean (± SEM) is shown; n=3; *P<0.05 452 




Figure S7: Knock down of CK5 impacts myoepithelial cell-cell junction proteins, Related to 455 
Figure 4 and 5. A) 3D cultures of CD49f+ EpCAM-/ basal progenitor-enriched MCF10A mammary 456 
epithelial cells and CK5 and CK14 KD cells. Cultures were maintained for two weeks, after which 457 
they were fixed with PFA and stained with Dsg3 (green) and DAPI (blue). Representative 458 
immunofluorescence images of 3D mammospheroids are shown with magnifications from the 459 
indicated areas below (yellow boxes). Bar 100 μm. B) Immunofluoresence microscopy was used to 460 
detect cell-substrate adhesions from ctrl and CK5 KD cell lines. Specific antibody against focal 461 
adhesion marker vinculin (red) was used. Phalloidin was used to stain actin cytoskeleton (green) and 462 
DAPI (blue) for nuclei. Bar 20 μm. C) Traction force microscopy was applied to study cell-exerted 463 
forces of the ctrl, CK5- and CK14 KD cells doublets. Representative force maps from ctrl, CK5- and 464 
CK14 KD doublets after 3h incubation. D) Quantification of the Root Mean Square (RMS) tractions 465 
and Strain Energy (SE). Data are presented as box-plots. n(ctrl)=12, n(CK5 KD)=10 and n(CK14 466 





Figure S8: Loss of CK5 impacts expression of laminin-5 and SLUG, Related to Figure 6. A) 471 
CD49f+ EpCAM-/ basal progenitor-enriched MCF10A mammary epithelial cells, CK5 KD and CK14 472 
KD cells were culture in 3D Matrigel for two weeks, after which they were fixed with PFA and 473 
stained with laminin-5 (See also Fig. 6A and B). Lineprofiles were drawn from the edge of the 474 
spheroid towards the center.  3-5 lineprofiles were drawn on each spheroid.  Peak values on point 3 475 
from lineprofiles were utilized for further analyses (Fig. 6B). B) Specific siRNAs against CK5 were 476 
 
utilized in MCF10A cells. Cellular lysates were performed four days after incubation and specific 477 
antibody against laminin-5 was used in Western blotting. GAPDH was used as a loading control. 478 
Upper laminin-5 band (150 kDa) corresponds to the precursor form and lower band (105 kDa) to the 479 
mature form. C) Quantification of the mature laminin-5 levels from CK5-depleted cells, related to 480 
Figure S7B. Laminin-5 levels were divided with corresponding GAPDH values, and values of 481 
untreated samples were set to 1. Mean (± SEM) is shown; n=4; **P<0.01 (paired t-test). D) Specific 482 
siRNAs against CK5 were utilized in MCF10A cells. Cellular lysates were performed four days after 483 
incubation and specific antibodies against CK5, SLUG and E-cadherin were used in Western blotting. 484 
GAPDH was used as a loading control. E) Quantification of the SLUG levels from CK5-depleted 485 
cells, related to Figure S7D. SLUG levels were divided with corresponding GAPDH values, and 486 
values of untreated samples were set to 1. Mean (± SEM) is shown; n=3; ***P<0.001 (paired t-test). 487 
F) Depletion of -SMA was performed with specific siRNAs in MCF10A cultures for four days. 488 
Cellular lysates from control siRNA and -SMA siRNA treated cells were used in Western blotting 489 
and specific antibodies against-SMA, SLUG and E-cadherin were utilized to assess their levels. 490 
GAPDH was used as a loading control.  491 
 492 
 493 
Figure S9. Passaged CK5 and CK14 KD cell lines undergo compensation by other cytokeratins, 494 
Related to Figures 3-6. A) Cellular lysates from passaged cell clones of ctrl (CD49f+ EpCAM-, 495 
enriched for basal progenitors), CK5 KD and CK14 KD cells were utilized in Western blotting. 496 
Specific antibodies against CK5, CK14 and SLUG were used to assess the levels of these proteins in 497 
clones that had been in culture for several weeks. GAPDH was used as a loading control. B) Cellular 498 
 
lysates from passaged cell clones of ctrl (CD49f+ EpCAM-, enriched for basal progenitors), CK5 KD 499 
and CK14 KD cells were utilized in Western blotting and Pan-keratin and CK6 antibodies were used 500 
to detect possible compensation of the loss of CK5 and CK14. GAPDH was used as a loading control. 501 
C)  Cellular lysates from passaged cell clones of ctrl (CD49f+ EpCAM-, enriched for basal 502 
progenitors), CK5 KD and CK14 KD cells were utilized in Western blotting. Antibodies against -503 
SMA, vimentin, P-cadherin and Dsg3 were used to assess the levels of these proteins in clones that 504 
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